Literature DB >> 12020260

Antiepileptic drug-induced bone loss in young male patients who have seizures.

Dennis L Andress1, Judy Ozuna, David Tirschwell, Lucinda Grande, Meshell Johnson, Arnold F Jacobson, William Spain.   

Abstract

BACKGROUND: Long-term antiepileptic drug (AED) therapy is a known risk factor for bone loss and fractures. Vitamin D deficiency is frequently cited as a cause for bone loss in patients who have seizures.
OBJECTIVE: To determine whether men who have seizures, but who are otherwise healthy, suffer substantial bone loss in the hip while taking AEDs. PATIENTS AND METHODS: We prospectively examined femoral neck bone mineral density (BMD) by dual-energy x-ray absorptiometry in 81 consecutive men, aged between 25 and 54 years old (mean age, 45 years), who were attending an outpatient seizure clinic. Low BMD values were analyzed for known risk factors for bone loss. Dual-energy x-ray absorptiometry scans were repeated in 54 patients, 12 to 29 months later (mean, 19 months), to assess the rate of change in BMD over time.
RESULTS: Multivariate linear regression analysis revealed that age (P<.001) and time receiving AEDs (P<.003) were the 2 important risk factors associated with low femoral neck BMD. Neither vitamin D deficiency, hypogonadism, cigarette smoking, nor excess alcohol intake were associated with low BMD after correcting for age and time on AEDs. Longitudinal analysis of femoral neck BMD revealed that only those in the youngest age group (25-44 years) showed significant declines in femoral neck BMD (1.8% annualized loss; 95% confidence interval, -3.1 to -0.9; P<.003) while receiving AED therapy. There was no evidence that a specific type of AED was more causally related to bone loss in this group although most patients were taking phenytoin sodium or carbamazepine during the longitudinal assessment.
CONCLUSIONS: Long-term AED therapy in young male patients who have seizures causes significant bone loss at the hip in the absence of vitamin D deficiency. Dual-energy x-ray absorptiometry scanning of the hip is useful in identifying patients who are particularly susceptible to rapid bone loss while taking AEDs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020260     DOI: 10.1001/archneur.59.5.781

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  38 in total

1.  The Association Between Antiepileptic Drugs and Bone Disease.

Authors:  Alison M. Pack
Journal:  Epilepsy Curr       Date:  2003-05       Impact factor: 7.500

Review 2.  Resurgence of vitamin D: Old wine in new bottle.

Authors:  Raju Vaishya; Vipul Vijay; Amit Kumar Agarwal; Jabed Jahangir
Journal:  J Clin Orthop Trauma       Date:  2015-03-26

3.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

Review 4.  Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

Authors:  Indra Ramasamy
Journal:  Clin Biochem Rev       Date:  2020-12

5.  Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

Authors:  Alison M Pack; Martha J Morrell; Robert Marcus; Leah Holloway; Edith Flaster; Silvia Doñe; Alison Randall; Cairn Seale; Elizabeth Shane
Journal:  Ann Neurol       Date:  2005-02       Impact factor: 10.422

Review 6.  Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.

Authors:  Sandra J Petty; Helen Wilding; John D Wark
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

7.  Antiepileptics and bone health.

Authors:  Christian Meier; Marius E Kraenzlin
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-10       Impact factor: 5.346

8.  Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.

Authors:  K E Ensrud; T S Walczak; T L Blackwell; E R Ensrud; E Barrett-Connor; E S Orwoll
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

9.  Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy.

Authors:  Sina Nettekoven; Alexander Ströhle; Birgit Trunz; Maike Wolters; Susanne Hoffmann; Rüdiger Horn; Martin Steinert; Georg Brabant; Ralf Lichtinghagen; Hans-Jürgen Welkoborsky; Ingrid Tuxhorn; Andreas Hahn
Journal:  Eur J Pediatr       Date:  2008-02-13       Impact factor: 3.183

10.  Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.

Authors:  Zhican Wang; Yvonne S Lin; Leslie J Dickmann; Emma-Jane Poulton; David L Eaton; Johanna W Lampe; Danny D Shen; Connie L Davis; Margaret C Shuhart; Kenneth E Thummel
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.